Natural products and their derivatives continue to play an important role in the drug pipeline. Over time, 7000 known structures have led to more than 20 commercial drugs, and about half of the new drugs approved in the last decade are based on natural products. Screening of new natural products and their analogs will continue, and be enhanced by modern methods such as metabolic engineering, synthetic biology, and structural analysis of compounds and the enzymes that produce them. For example, new biosynthetic routes are being built around engineered systems such as the modular polyketide synthases to produce new compounds. There are also still a tremendous number of new microbial natural products to be explored, as evidenced by the genomic sequencing data coming forth. Nevertheless, the discovery of new compounds remains an adventitious endeavor. Genome mining efforts to identify interesting clusters and to predict what natural products might come from these clusters of genes are beginning to produce hypotheses;however the homology of the enzymes to known enzymes is generally low. We propose to create a new partnership, named the Natural Products Partnership, within the PSI Biology Network framework to play strong joint roles in both the identification of new natural product pathways and the subsequent discovery of new natural product-based pharmaceuticals by revealing the structures and active sites of novel enzymes, characterizing the enzymatic reactions of the gene products, identifying new natural products and thus offering opportunities to identify and customize the pathways by altering specificities and/or identifying novel proteins or domains with desired enzymatic properties. The combination of the PSI Network Centers with their high-throughput structure determination capability and the biology-driven team of natural products scientists through the Natural Products Partnership are strongly positioned to create a high impact program. The experience of the structural biologists with PSI activities and their leadership in developing technologies and infrastructure in the PSI program will make a smooth transition to PSI Biology activities possible.

Public Health Relevance

Natural products and their derivatives continue to play an important role in the drug pipeline, with many in actual use or in trials. Our proposed Natural Products Partnership will combine the high-throughput capabilities of the PSI Network with state-of-the-art natural product research to yield new leads and new reactions for creation of drug candidates.

Agency
National Institute of Health (NIH)
Institute
National Institute of General Medical Sciences (NIGMS)
Type
Research Project--Cooperative Agreements (U01)
Project #
5U01GM098248-03
Application #
8616735
Study Section
Special Emphasis Panel (ZGM1-CBB-0 (BP))
Program Officer
Ainsztein, Alexandra M
Project Start
2011-09-30
Project End
2016-01-31
Budget Start
2014-02-01
Budget End
2015-01-31
Support Year
3
Fiscal Year
2014
Total Cost
$675,317
Indirect Cost
$144,814
Name
Rice University
Department
Biochemistry
Type
Schools of Arts and Sciences
DUNS #
050299031
City
Houston
State
TX
Country
United States
Zip Code
77005
Weerth, R Sophia; Michalska, Karolina; Bingman, Craig A et al. (2015) Structure of a cupin protein Plu4264 from Photorhabdus luminescens subsp. laumondii TTO1 at 1.35 Ă… resolution. Proteins 83:383-8
Singh, Shanteri; Zhang, Jianjun; Huber, Tyler D et al. (2014) Facile chemoenzymatic strategies for the synthesis and utilization of S-adenosyl-(L)-methionine analogues. Angew Chem Int Ed Engl 53:3965-9
Desai, Kevin K; Cheng, Chin L; Bingman, Craig A et al. (2014) A tRNA splicing operon: Archease endows RtcB with dual GTP/ATP cofactor specificity and accelerates RNA ligation. Nucleic Acids Res 42:3931-42
Cao, Hongnan; Walton, Jonathan D; Brumm, Phil et al. (2014) Structure and substrate specificity of a eukaryotic fucosidase from Fusarium graminearum. J Biol Chem 289:25624-38
Park, Mi Seul; Bitto, Eduard; Kim, Kyung Rok et al. (2014) Crystal structure of human protein N-terminal glutamine amidohydrolase, an initial component of the N-end rule pathway. PLoS One 9:e111142
Wang, Fengbin; Singh, Shanteri; Zhang, Jianjun et al. (2014) Understanding molecular recognition of promiscuity of thermophilic methionine adenosyltransferase sMAT from Sulfolobus solfataricus. FEBS J 281:4224-39
Book, Adam J; Yennamalli, Ragothaman M; Takasuka, Taichi E et al. (2014) Evolution of substrate specificity in bacterial AA10 lytic polysaccharide monooxygenases. Biotechnol Biofuels 7:109
Desai, Kevin K; Bingman, Craig A; Cheng, Chin L et al. (2014) Structure of RNA 3'-phosphate cyclase bound to substrate RNA. RNA 20:1560-6
Elshahawi, Sherif I; Ramelot, Theresa A; Seetharaman, Jayaraman et al. (2014) Structure-guided functional characterization of enediyne self-sacrifice resistance proteins, CalU16 and CalU19. ACS Chem Biol 9:2347-58
Lomax, Jo E; Bianchetti, Christopher M; Chang, Aram et al. (2014) Functional evolution of ribonuclease inhibitor: insights from birds and reptiles. J Mol Biol 426:3041-56

Showing the most recent 10 out of 16 publications